Literature DB >> 30481600

Apixaban and rivaroxaban in patients with cerebral venous thrombosis.

Fahrettin Covut1, Tariq Kewan2, Oscar Perez2, Monica Flores2, Abdo Haddad3, Hamed Daw3.   

Abstract

Entities:  

Keywords:  Apixaban; Cerebral venous thrombosis; DOAC; Direct oral anticoagulants; Rivaroxaban

Mesh：

Substances：

Year:  2018        PMID： 30481600     DOI： 10.1016/j.thromres.2018.11.018

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  9 in total

1.  [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].

Authors: 
Journal:  Neurologia       Date:  2021-05-06       Impact factor: 3.109

Review 2.  Evidence-Based Minireview: Should warfarin or a direct oral anticoagulant be used in patients presenting with thrombosis in the splanchnic or cerebral veins?

Authors:  Carol Mathew; Marc Zumberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  J Clin Med       Date:  2020-03-10       Impact factor: 4.241

4.  Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.

Authors:  Gauruv Bose; Justin Graveline; Vignan Yogendrakumar; Risa Shorr; Dean A Fergusson; Gregoire Le Gal; Jonathan Coutinho; Marcelo Mendonça; Miguel Viana-Baptista; Simon Nagel; Dar Dowlatshahi
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

5.  Direct oral anticoagulants for unusual-site venous thromboembolism.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  Res Pract Thromb Haemost       Date:  2021-01-28

6.  Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression.

Authors:  Xiaohui Dong; Xiaohui Liu; Yanqing Liu; Lili Jiang; Huiping Zhang; Bofeng Liu
Journal:  Comput Math Methods Med       Date:  2021-12-31       Impact factor: 2.238

7.  A Cohort Study of Rivaroxaban Combined with D-Dimer Dynamic Monitoring in the Prevention of Deep Venous Thrombosis after Knee Arthroplasty.

Authors:  Yongyong Dong; Guangbin Duan; Huihui Wang; Jia Ru; Yong Cui
Journal:  Comput Math Methods Med       Date:  2022-04-19       Impact factor: 2.809

8.  Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination.

Authors: 
Journal:  Neurologia (Engl Ed)       Date:  2021-05-29

9.  [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].

Authors: 
Journal:  Neurologia       Date:  2021-05-06       Impact factor: 3.109
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.